Literature DB >> 62386

Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway.

R D Schreiber, O Götze, H J Müller-Eberhard.   

Abstract

Nephritic factor (NF) has a molecular weight of 170,000 and is composed of two disulfide-linked 85,000-dalton chains. NF assembles the fluid phase C3 convertase from Factors B and D, C3, and magnesium by physically incorporating itself into the enzyme complex. NF exerts its stabilizing effect on the cell-bound C3/C5 convertase, EC3b,B, by physically associating itself with this complex. On decay of the cell-bound enzyme NF is released into the fluid phase and retains its binding and stabilizing potential. Its activity is resistant to diisopropylfluorophosphate treatment. Because NF causes agglutination of EC3b,B, it must be endowed with more than one binding site.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62386     DOI: 10.1111/j.1365-3083.1976.tb03020.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

1.  The immunogloblin nature of nephritic factor (NeF).

Authors:  D M Scott; N Amos; J G Sissons; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

2.  Heterogeneity of nephritic factor and its identification as an immunoglobulin.

Authors:  A E Davis; J B Ziegler; E W Gelfand; F S Rosen; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.

Authors:  M R Daha; L A Van Es
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

4.  The role of carbohydrate in the structure and function of nephritic factor.

Authors:  D M Scott; N Amos; S R Bartolotti
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  C J Parker; P J Baker; W F Rosse
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.

Authors:  U E Nydegger; D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertase.

Authors:  Y Tanuma; H Ohi; M Hatano
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

8.  Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A Vanes; A Cats
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

9.  Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.

Authors:  D V Devine; W F Rosse
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.

Authors:  D V Devine; R S Siegel; W F Rosse
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.